Hexarelin Peptide: A Research Overview of Structure, GHS-R1a and CD36 Studies
The hexarelin peptide is a synthetic six-residue member of the growth hormone-releasing peptide (GHRP) family. It is interesting to researchers for two reasons: it acts at the growth hormone secretagogue receptor (GHS-R1a, the receptor later found to bind ghrelin), and it was one of the first ligands shown to bind a second, unrelated receptor, the scavenger receptor CD36. This overview covers its structure, its research history, what published studies have examined, and what to check when sourcing it for laboratory work. It is written for researchers and makes no health or therapeutic claims.
What is the hexarelin peptide?
Hexarelin is the hexapeptide His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2. PubChem lists its molecular formula as C47H58N12O6 with a molecular weight of about 887.0 g/mol (PubChem CID 6918297). Two features stand out in the sequence: it contains D-amino acids, which are not used by ribosomal protein synthesis, and its C-terminus is amidated. Both are typical of the synthetic GHRPs.
| Property | Value |
|---|---|
| Sequence | His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Length | 6 residues (hexapeptide) |
| Formula / MW | C47H58N12O6 / ~887.0 g/mol |
| Family | Growth hormone-releasing peptides (GHRPs) |
| Parent compound | GHRP-6 (D-Trp replaced by D-2-methyl-Trp) |
| Reported binding partners | GHS-R1a (ghrelin receptor); CD36 |
Origins: from GHRP-6 to hexarelin
The GHRPs were developed as unnatural, synthetic peptides years before their receptor or natural ligand was known; Cyril Bowers’ historical review traces that path from the 1970s through the discovery of ghrelin (Bowers, 2012). Hexarelin was designed as an analog of GHRP-6 in which a tryptophan was replaced by the chemically more stable 2-methyl-tryptophan. Its original rat pharmacology was reported by Deghenghi and colleagues in 1994, who compared its growth hormone-releasing activity with GHRP-6 in infant and adult rats (Deghenghi et al., 1994).
The receptor story: GHS-R1a and ghrelin
In 1996, Howard and colleagues cloned a G protein-coupled receptor from pituitary and hypothalamus that responded to synthetic growth hormone secretagogues (Howard et al., 1996). Its endogenous ligand was identified in 1999 as ghrelin, an acylated peptide isolated from the stomach (Kojima et al., 1999). Hexarelin is therefore often described in the literature as a synthetic ligand of the ghrelin receptor, which is why it appears in studies alongside other secretagogues such as ipamorelin and the CJC-1295 / ipamorelin blend.
The CD36 connection
What makes hexarelin unusual is a second binding partner. Using a photoactivatable hexarelin derivative on rat cardiac membranes, Bodart and colleagues identified the binding protein as CD36, a multifunctional scavenger receptor, and reported that responses seen in perfused hearts were absent in hearts lacking CD36 (Bodart et al., 2002). A follow-up photoaffinity study mapped the binding region to the CD36 segment Asn132-Glu177 (Demers et al., 2004).
That finding opened a line of cell and rodent work on CD36-linked signaling. Examples include a study in THP-1 macrophages and apolipoprotein E-null mice looking at PPAR-gamma-dependent sterol transporter expression (Avallone et al., 2006) and a study of mitochondrial and lipid-handling gene expression in 3T3-L1 adipocytes and in CD36-null mice (Rodrigue-Way et al., 2007). A concise review of the cardiovascular literature is available from Mao and colleagues (Mao et al., 2014).
How researchers use hexarelin in study design
- As a dual-receptor probe. Because it binds both GHS-R1a and CD36, it is used to ask which receptor carries a given response, often by comparing wild-type and receptor-deficient models.
- As a comparator. It is compared with GHRP-6, ghrelin and other secretagogues to separate GHS-R1a effects from structure-specific ones.
- As a tool for CD36 biology. Photoaffinity derivatives were central to mapping the CD36 binding site.
A practical design point: because receptor expression differs across cell types and species, any experiment should record the model, the receptor background, the material source and the lot number so that results can be compared with the published work.
Limits of the current evidence
Most of the mechanistic literature cited above comes from cell culture, isolated organs and rodents, and much of the CD36 work comes from a small number of research groups. Results in one model do not automatically translate to another. None of these studies establishes any effect in people, and nothing here should be read that way.
Sourcing hexarelin for research: what to verify
Because hexarelin differs from GHRP-6 by a single methyl group, identity testing matters: a mass spectrometry result should match the expected mass for hexarelin, not GHRP-6. Look for HPLC purity, a lot number that matches your vial, and the name of the independent lab. Our lab testing and COA page explains how we document batches, and our COA interpretation guide walks through the numbers. Hexarelin 5mg is listed in our research catalog for laboratory use only.
Handling and storage in the lab
Like most lyophilized peptides, hexarelin is usually kept sealed, cold, dry and away from light until use. Tryptophan-containing sequences can be sensitive to oxidation and light, so limit exposure once a vial is opened. For reconstitution choices, see our guide to bacteriostatic vs. sterile water.
Frequently Asked Questions
What is hexarelin?
Hexarelin is a synthetic hexapeptide (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2) in the growth hormone-releasing peptide family. It was developed as an analog of GHRP-6 and is sold as a lyophilized research peptide for laboratory use only.
How is hexarelin different from GHRP-6?
Hexarelin replaces the D-tryptophan of GHRP-6 with D-2-methyl-tryptophan, a change described in the original 1994 report as more chemically stable. The single methyl group means identity testing by mass spectrometry is important to tell them apart.
Which receptors does hexarelin bind?
Published studies report binding to the growth hormone secretagogue receptor GHS-R1a, the receptor for ghrelin, and to the scavenger receptor CD36. The CD36 interaction was identified by photoaffinity labeling of rat cardiac membranes in 2002.
What should a hexarelin COA show?
It should show HPLC purity, a mass spectrometry result matching the expected mass of about 887 g/mol, a lot number that matches your vial, and the name of the independent testing lab. A report date and verification ID are useful extras.
Research use only. All Pure Tested Peptides products are sold strictly for laboratory research and are not for human or veterinary use. Nothing in this article is medical advice or a claim that any compound diagnoses, treats, cures, or prevents any condition.




Leave a Reply
Want to join the discussion?Feel free to contribute!